Paolo Tarantino, MD, PhD

Breast medical oncologist and clinical researcher at Dana-Farber Cancer Institute and Harvard Medical School

Published Articles (1)

Antibody-Drug Conjugates in Solid Tumors: From Magic Bullet to Standard of Care

April 30, 2026

Antibody-drug conjugates (ADCs) are transforming cancer care by delivering targeted chemotherapy with improved efficacy across multiple solid tumors, redefining treatment from late-line therapy to frontline standard.